GSK/Adolor Entereg Gets Standard Review For Postoperative Ileus Despite Fast Track Status

NDA submission was completed June 25 under FDA's continuous marketing application Pilot 1 program. There are no approved POI treatments, firm says. Chronic constipation and opioid bowel dysfunction alvimopan filings are projected for 2007.